Yes, reports and studies suggest Ozempic (semaglutide) and similar GLP-1 drugs may be linked to increased risks of depression, anxiety, and suicidal thoughts, though regulators haven't confirmed a direct causal link, advising close monitoring for mood changes as potential side effects, especially in those with a history of mental health issues, as the medication might affect mood-regulating brain chemicals like dopamine.
While Ozempic itself doesn't specifically cause mental health conditions, the changes in appetite, weight, and decrease in energy levels can sometimes affect mood. For someone with a history of depression or anxiety, these effects might feel more pronounced.
There isn't a set time for patients to stay on Ozempic. If you experience side effects, you should speak with your provider to determine if you need to stop taking Ozempic. Be sure to speak to your doctor first before discontinuing the drug.
The Takeaway. Ozempic and related GLP-1 drugs stay in the body for more than one week, so missing or delaying one dose is unlikely to have significant immediate side effects. Eventually, the drug's effects will begin to wear off, which should cause your hunger to return.
But about half of people with obesity on this class of medications, called glucagon-like peptide agonists or GLP-1s, stop taking it within a year. Studies suggest that most people discontinue their use due to the high cost and adverse gastrointestinal side-effects.
"Ozempic face" as a side effect of GLP-1 drugs
WHAT IS OZEMPIC PERSONALITY? “Ozempic personality” refers to mood and behavior changes in people taking the drugs. According to numerous reports, GLP-1 RAs are causing mental health disorders like anxiety, depression, and suicidal thoughts in users.
Nausea is the most common Ozempic side effect. Still, not everyone has it. About 1 in 5 people in the clinical trial had it. Nausea is usually mild to moderate and at its worst when you first start the drug or when you increase your dose.
Ozempic is injected once a week. So about a week after stopping the medicine, you will start to notice that your hunger and cravings may return. You may not feel as full for as long. While Ozempic doesn't usually have withdrawal symptoms, people with type 2 diabetes may experience high blood sugar levels.
Basically, if you develop Ozempic feet, it means your rapid weight loss has sped up the natural process of fat pad atrophy in your feet. Some people are upset about this because it negatively impacts the appearance of their feet: the skin starts to sag, and the veins of the feet appear more prominent.
It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not use Ozempic® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Summary: Ozempic does not wear off by the end of the week when used as prescribed, as it is specifically designed with a seven-day half-life to maintain therapeutic effects throughout the entire weekly dosing interval.
There's no evidence that Ozempic directly causes brain fog. But it can cause side effects that make you feel tired and cause trouble concentrating. Research suggests that Ozempic may be good for brain health by lowering the risk of stroke and dementia.
While the official side effect profile of Ozempic, provided by the manufacturer, does not prominently list anxiety and panic attacks, some patients have reported experiencing these symptoms.
Some possible interactions of Ozempic include other diabetes treatments, like insulin and oral medications, antimalarials, anticoagulants, digoxin, phenytoin, certain antibiotics, and blood pressure medications.
If you're considering stopping Ozempic or Wegovy, it's important to do so under the guidance of your doctor. They may recommend tapering down your dosage gradually to help your body adjust. Stopping suddenly can cause more noticeable side effects, so a gradual reduction is often the safer approach.
“The current evidence doesn't support increased incidence of depression with Ozempic or other GLP-1s, but clinical vigilance is still warranted,” says Dr. Cohen. “That's because rare cases of semaglutide-associated depressive episodes have been published, which supports the need for individualized monitoring.”
Summary: Ozempic does not directly increase serotonin levels in the brain. Semaglutide is a GLP-1 receptor agonist that works through cyclic AMP signalling pathways, not serotonergic systems. The medication improves glycaemic control through glucose-dependent insulin secretion and glucagon suppression.
The researchers found that people using it had an increased risk of gastrointestinal conditions (like nausea and vomiting), abdominal pain, low blood pressure and arthritis. Surprisingly, the researchers also uncovered an increased risk of uncommon, yet serious, pancreas and kidney conditions.
"Ozempic hands" is a slang term for the visible changes in hands due to rapid fat loss from GLP-1 drugs like Ozempic, making them look thinner, bonier, and more aged with prominent veins, tendons, and thinner skin, as subcutaneous fat diminishes and skin doesn't fully contract quickly. It's not a formal diagnosis but a common cosmetic effect of significant weight loss, similar to "Ozempic face".
Ozempic is a glucagon-like peptide-1 receptor agonist (GLP-1RA) that slows down stomach emptying. It may present with mild to moderate stomach upset and nausea. These symptoms could be temporary and last for a few weeks. To relieve indigestion symptoms, eat smaller portions of foods throughout the day.
'Ozempic legs' is an informal term describing visible changes in leg appearance—such as reduced fat volume, increased muscle and vein visibility, and looser skin—that some people experience during treatment with semaglutide (Ozempic) or similar GLP-1 receptor agonists.
You Won't Lose Weight on Ozempic Forever. People taking the drug and similar medications will hit an inevitable, and necessary, plateau. Here's why. Kimmy Meinecke blamed herself when she stopped losing weight.